Pharma and Biotech
Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -39.3% | -5.1% |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | 0.9 |
PEG | n/a | n/a |
Pr/Revenue | 1.9 | 2.2 |
Pr/Book | 0.8 |
Latest | F'cast | |
---|---|---|
Revenue | -13.1% | -11.8% |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Sep-20 | 105.57 | (22.57) | (3.80)p | n/a | n/a | n/a | n/a | 0.0% |
30-Sep-21 | 125.06 | (9.18) | (1.93)p | n/a | n/a | n/a | n/a | 0.0% |
30-Sep-22 | 157.71 | (21.38) | (4.34)p | n/a | n/a | n/a | n/a | 0.0% |
30-Sep-23 | 103.96 | (24.70) | (3.21)p | n/a | n/a | n/a | n/a | 0.0% |
30-Sep-24 | 90.36 | (45.92) | (5.99)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Sep-25 | 79.70 | (4.10) | 26.63p | 0.9 | n/a | n/a | n/a | 0.0% |
30-Sep-26 | 83.70 | 11.30 | 1.10p | 21.1 | n/a | -96% | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Result of Tender Offer | 25-Jul-2025 | 07:00 | RNS |
Board and Management Changes | 21-Jul-2025 | 12:00 | RNS |
Form 8.3 - BENCHMARK HOLDINGS PLC | 14-Jul-2025 | 15:10 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 21.00p |
Change Today | -2.20p |
% Change | -9.48 % |
52 Week High | 42.00 |
52 Week Low | 17.70 |
Volume | 250,854 |
Shares Issued | 742.42m |
Market Cap | £155.91m |
Beta | 0.07 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
10:16 | 2,000 @ 21.60p |
08:31 | 50,000 @ 21.45p |
09:06 | 5,064 @ 21.03p |
08:58 | 5 @ 21.00p |
08:58 | 7,500 @ 21.00p |
CEO | Trond Williksen |
Chair | Tripp Lane |
You are here: research